In conclusion, our study reveals the essential role of IGF2BP2 as an m6A-binding protein in the pathogenesis of liver fibrosis through the regulation of glycolytic metabolism and extends the potential role of lactylation in the activation of HSCs and liver fibrosis (Fig. 8). The gene discussed is IGF2BP2; the disease is Hepatic fibrosis.